Discover
MGNX
MacroGenics, Inc.
4.54
2 x 4.08
1 x 5.21
bid
ask
+
0.22
5.09%
26 @ 04:00 PM
4.45 -0.09 (2.07%)
| Ytd | 181.99% | |
| 1y | 208.84% |
4.31
day range
4.55
1.29
52 week range
5.08
| Open | 4.31 | Prev Close | 4.32 | Low | 4.31 | High | 4.55 | Mkt Cap | 288.58M |
| Vol | 648.39K | Avg Vol | 1.15M | EPS | -1.10 | P/E | -4.13 | Forward P/E | -1.34 |
| Beta | 1.18 | Short Ratio | 7.20 | Inst. Own | 93.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 4.25 | 200-d Avg | 2.63 | 1yr Est | 7.38 |
| Income Statement | |||
| Total Revenue | 20.78M | ||
| Revenues (USD) | 20.78M | ||
| Cost of Revenue | 9.53M | ||
| Gross Profit | 11.25M | ||
| Operating Expenses | 44.68M | ||
| Research and Development Expense | 34.97M | ||
| Selling, General and Administrative Expense | 9.71M | ||
| Operating Income | -33.44M | ||
| Interest Expense | 4.89M | ||
| Net Income | -36.77M | ||
| Net Income Common Stock | -36.77M | ||
| Net Income Common Stock (USD) | -36.77M | ||
| Consolidated Income | -36.77M | ||
| Earnings per Basic Share | -0.58 | ||
| Earnings per Basic Share (USD) | -0.58 | ||
| Earnings per Diluted Share | -0.58 | ||
| Earning Before Interest & Taxes (EBIT) | -31.88M | ||
| Earning Before Interest & Taxes (USD) | -31.88M | ||
| Weighted Average Shares | 63.45M | ||
| Weighted Average Shares Diluted | 63.45M | ||
| Balance Sheet | |||
| Cash and Equivalents | 66.52M | ||
| Cash and Equivalents (USD) | 66.52M | ||
| Investments | 87.71M | ||
| Investments Current | 87.71M | ||
| Trade and Non-Trade Receivables | 10.43M | ||
| Current Assets | 182.52M | ||
| Property, Plant & Equipment Net | 33.97M | ||
| Total Assets | 217.87M | ||
| Debt Current | 5.21M | ||
| Total Debt | 105.22M | ||
| Current Liabilities | 95.94M | ||
| Debt Non-Current | 100.01M | ||
| Total Liabilities | 196.68M | ||
| Accumulated Retained Earnings (Deficit) | -1.28B | ||
| Accumulated Other Comprehensive Income | -27.00K | ||
| Shareholders Equity | 21.20M | ||
| Shareholders Equity (USD) | 21.20M | ||
| Assets Non-Current | 35.35M | ||
| Total Debt (USD) | 105.22M | ||
| Deferred Revenue | 67.99M | ||
| Inventory | 9.50M | ||
| Liabilities Non-Current | 100.74M | ||
| Trade and Non-Trade Payables | 4.29M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.11M | ||
| Net Cash Flow from Financing | -207.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.30M | ||
| Capital Expenditure | -344.00K | ||
| Issuance (Purchase) of Equity Shares | 11.00K | ||
| Net Cash Flow from Investing | 45.32M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 45.66M | ||
| Net Cash Flow from Operations | -35.81M | ||
| Share Based Compensation | 2.65M | ||